“No Actual Negotiation” in IRA, Says AstraZeneca in Motion to Strike Down Law

Around the same time AstraZeneca was signing its price negotiation agreement with CMS for its diabetes drug Farxiga, which is included in the Inflation Reduction Act’s (IRA) first list of Medicare Part D high cost drugs, the company was also filing a motion for summary judgment for the courts to declare the IRA unconstitutional.
Source: Drug Industry Daily